Page last updated: 2024-08-21

dronabinol and Acantholysis Bullosa

dronabinol has been researched along with Acantholysis Bullosa in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bolling, MC; Duipmans, JC; Renken, RJ; Schräder, NHB; Sörös, P; Vermeulen, KM; Wolff, AP1
Duipmans, JC; Jonkman, MF; Molenbuur, B; Schräder, NHB; Wolff, AP1
Martinez, AE1

Trials

1 trial(s) available for dronabinol and Acantholysis Bullosa

ArticleYear
The C4EB study-Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study.
    PloS one, 2022, Volume: 17, Issue:12

    Topics: Adult; Cannabidiol; Chronic Pain; Cross-Over Studies; Double-Blind Method; Dronabinol; Epidermolysis Bullosa; Humans; Quality of Life; Randomized Controlled Trials as Topic

2022

Other Studies

2 other study(ies) available for dronabinol and Acantholysis Bullosa

ArticleYear
Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a report of three cases.
    The British journal of dermatology, 2019, Volume: 180, Issue:4

    Topics: Administration, Sublingual; Adult; Analgesics, Opioid; Cannabidiol; Cannabis; Dronabinol; Drug Combinations; Drug Therapy, Combination; Epidermolysis Bullosa; Female; Humans; Male; Middle Aged; Netherlands; Pain; Pain Measurement; Plant Oils; Treatment Outcome

2019
Time to drop the stigma: cannabinoids are drugs that may alleviate pain in people with epidermolysis bullosa.
    The British journal of dermatology, 2019, Volume: 180, Issue:4

    Topics: Cannabidiol; Cannabinoids; Dronabinol; Epidermolysis Bullosa; Humans; Pain

2019